Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

How I treat type 2B von Willebrand disease

Rebecca Kruse-Jarres, Jill M. Johnsen

Blood (2018) 131 (12): 1292–1300.

https://doi.org/10.1182/blood-2017-06-742692

Published: 2018

Journal Articles

Metabolic and Endocrin Complications of Pediatric, Adolescent and Young Adult Acute Lymphoblastic Leukemia: Single Centre Experience

Bulent Zulfikar, Prof, Basak Koc, MD, Pınar Ozturk, MD

Blood (2017) 130 (Supplement 1): 5009.

https://doi.org/10.1182/blood.V130.Suppl_1.5009.5009

Published: 2017

Journal Articles

Risk of Hyponatremia and Associated Clinical Characteristics in Patients with Acute Lymphoblastic Leukemia after CD19 Targeted Chimeric Antigen Receptor (CAR) T-Cells

Brianne N. Dixon, PharmD, Ryan J. Daley, PharmD, BCOP, Troy Z. Horvat, PharmD, BCOP, Larry W Buie, PharmD, BCOP, FASHP, Meier Hsu, MS, Sheron Latcha, MD, Renier J. Brentjens, MD PhD, Jae H. Park, MD

Blood (2017) 130 (Supplement 1): 3584.

https://doi.org/10.1182/blood.V130.Suppl_1.3584.3584

Published: 2017

Journal Articles

Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels

Michelle Lavin, Sonia Aguila, Sonja Schneppenheim, Niall Dalton, Kenneth L. Jones, Jamie M. O’Sullivan, Niamh M. O’Connell, Kevin Ryan, Barry White, Mary Byrne, Marie Rafferty, Mairead M. Doyle, Margaret Nolan, Roger J. S. Preston, Ulrich Budde, Paula James, Jorge Di Paola, James S. O’Donnell

Blood (2017) 130 (21): 2344–2353.

https://doi.org/10.1182/blood-2017-05-786699

Published: 2017

Includes: Supplemental data

Journal Articles

Concordance of DDAVP Response in Siblings with Von Willebrand Disease or Hemophilia a

Erin Ryan, BS, Madhvi Rajpurkar, MD, Carol Lum, Michael U Callaghan, MD

Blood (2015) 126 (23): 4684.

https://doi.org/10.1182/blood.V126.23.4684.4684

Published: 2015

Journal Articles

Factor H (FH) Is Released Slowly and Continuously from Human Endothelial Cells (ECs): FH Is Not Packaged in Weibel-Palade Bodies or Secreted in Response to EC Stimulation

Sarah E Sartain, MD, Nancy A Turner, BS, Hui Shiu-Ki, MD, Charles G. Minard, PhD, Joel L Moake, MD

Blood (2014) 124 (21): 4175.

https://doi.org/10.1182/blood.V124.21.4175.4175

Published: 2014

Journal Articles

Biologic Response and Adverse Events To Stimate In Patients With Von Willebrand Disease

Xiangqian Song, MD. PhD., Leonard A. Valentino, MD, FAAP, Mindy L. Simpson, MD, FAAP, Lisa Boggio, MD

Blood (2013) 122 (21): 2365.

https://doi.org/10.1182/blood.V122.21.2365.2365

Published: 2013

Journal Articles

Laboratory Response to Desmopressin in Children with Von Willebrand Disease: Results of a Multicenter Survey

Bianca Huhn, Volker Aumann, Andre Hofmann, Karim Kentouche, Axel Sauerbrey, Harry Sirb, Thomas Winkelmann, Ralf Knoefler

Blood (2008) 112 (11): 4517.

https://doi.org/10.1182/blood.V112.11.4517.4517

Published: 2008

Journal Articles

Temporal Variation in Intensity of Laboratory Response to DDAVP.

Minh H. Tran, DO, Andrea L. Cortese Hassett, Ph.D.

Blood (2007) 110 (11): 3970.

https://doi.org/10.1182/blood.V110.11.3970.3970

Published: 2007

Journal Articles

Epac Is Involved in cAMP-Mediated Exocytosis of Weibel-Palade Bodies in Endothelial Cells through the Activation of the Small GTPase Rap1.

Jan Voorberg, PhD, Ruben Bierings, MSc, Mar Fernandez, PhD, Jan A. van Mourik, PhD

Blood (2007) 110 (11): 2157.

https://doi.org/10.1182/blood.V110.11.2157.2157

Published: 2007

Journal Articles

The Effect of Aquaporin 2 Gene Variations on Plasma Levels of von Willebrand Factor and Factor VIII and on the Risk of Venous Thrombosis.

Anne Yael Nossent, MSc, Johanne H. Ellenbroek, Bsc, Marijke Frolich, PhD, Frits R. Rosendaal, Md PhD, Rogier M. Bertina, PhD, Nine V.A.M. Knoers, Md PhD, Jeroen C.J. Eikenboom, Md PhD

Blood (2007) 110 (11): 1749.

https://doi.org/10.1182/blood.V110.11.1749.1749

Published: 2007

Journal Articles

Syndrome of Inappropriate Secretion of Anti-Diuretic Hormone in Children with Acute Lymphoblastic Leukemia.

Anupama S. Borker, MD, Sabrina Hutchins, MD, Robin Grant, Nobuko Hijiya, MD, John T. Sandlund, MD, Monika L. Metzger, MD, Sima Jeha, MD, Bassem I. Razzouk, MD, Raul C. Ribeiro, MD, Jeffrey E. Rubnitz, MD, Melissa M. Hudson, MD, Mary V. Relling, MD, Ching-Hon Pui, MD, Scott Howard, MD

Blood (2006) 108 (11): 4474.

https://doi.org/10.1182/blood.V108.11.4474.4474

Published: 2006

Journal Articles

Severe Bleeding Complications during Antiepileptic Treatment with Valproic Acid in Children: A Description of Four Cases.

Elvira Cannizzaro, MD, Manuela Albisetti, MD, Eva Bergstraesser, MD, Franziska Scherer, MD, Bernhard Schmitt, MD, Gabriele Wohlrab, MD, Markus Schmugge, MD

Blood (2005) 106 (11): 2155.

https://doi.org/10.1182/blood.V106.11.2155.2155

Published: 2005

Journal Articles

Transition of Human Embryonic Stem Cell-Derived Endothelial Cells to Smooth Muscle Cells in Culture as a Model for Vascular Development.

Petra Obrtlikova, MD, Jeffrey J. Ross, PhD, Aernout Luttun, PhD, Joan D. Beckman, BS, Susan A. Keirstead, PhD, Dan S. Kaufman, MD, PhD

Blood (2005) 106 (11): 3683.

https://doi.org/10.1182/blood.V106.11.3683.3683

Published: 2005

Journal Articles

Critical independent regions in the VWF propeptide and mature VWF that enable normal VWF storage

Sandra L. Haberichter, Paula Jacobi, Robert R. Montgomery

Blood (2003) 101 (4): 1384–1391.

https://doi.org/10.1182/blood-2002-07-2281

Published: 2003

Journal Articles

Clinical Significance of Inhibitors in Acquired von Willebrand Syndrome

Hiroshi Mohri, Shigeki Motomura, Heiwa Kanamori, Michio Matsuzaki, Shin-ichiro Watanabe, Atsuo Maruta, Fumio Kodama, Takao Okubo

Blood (1998) 91 (10): 3623–3629.

https://doi.org/10.1182/blood.V91.10.3623

Published: 1998

Journal Articles

New variant of von Willebrand disease with defective binding to factor VIII

M Nishino, JP Girma, C Rothschild, E Fressinaud, D Meyer

Blood (1989) 74 (5): 1591–1599.

https://doi.org/10.1182/blood.V74.5.1591.1591

Published: 1989

Journal Articles

The heterogeneity of type IIA von Willebrand's disease: studies with protease inhibitors

J Batlle, MF Lopez Fernandez, M Campos, B Justica, C Berges, JL Navarro, JM Diaz Cremades, CK Kasper, JA Dent, ZM Ruggeri

Blood (1986) 68 (6): 1207–1212.

https://doi.org/10.1182/blood.V68.6.1207.1207

Published: 1986

Journal Articles

DDAVP enhances platelet adherence and platelet aggregate growth on human artery subendothelium

KS Sakariassen, M Cattaneo, A v.d. Berg, ZM Ruggeri, PM Mannucci, JJ Sixma

Blood (1984) 64 (1): 229–236.

https://doi.org/10.1182/blood.V64.1.229.229

Published: 1984

NARROW

How I treat type 2B von Willebrand disease

Metabolic and Endocrin Complications of Pediatric, Adolescent and Young Adult Acute Lymphoblastic Leukemia: Single Centre Experience

Risk of Hyponatremia and Associated Clinical Characteristics in Patients with Acute Lymphoblastic Leukemia after CD19 Targeted Chimeric Antigen Receptor (CAR) T-Cells

Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels

Concordance of DDAVP Response in Siblings with Von Willebrand Disease or Hemophilia a

Factor H (FH) Is Released Slowly and Continuously from Human Endothelial Cells (ECs): FH Is Not Packaged in Weibel-Palade Bodies or Secreted in Response to EC Stimulation

Biologic Response and Adverse Events To Stimate In Patients With Von Willebrand Disease

Laboratory Response to Desmopressin in Children with Von Willebrand Disease: Results of a Multicenter Survey

Temporal Variation in Intensity of Laboratory Response to DDAVP.

Epac Is Involved in cAMP-Mediated Exocytosis of Weibel-Palade Bodies in Endothelial Cells through the Activation of the Small GTPase Rap1.

The Effect of Aquaporin 2 Gene Variations on Plasma Levels of von Willebrand Factor and Factor VIII and on the Risk of Venous Thrombosis.

Syndrome of Inappropriate Secretion of Anti-Diuretic Hormone in Children with Acute Lymphoblastic Leukemia.

Severe Bleeding Complications during Antiepileptic Treatment with Valproic Acid in Children: A Description of Four Cases.

Transition of Human Embryonic Stem Cell-Derived Endothelial Cells to Smooth Muscle Cells in Culture as a Model for Vascular Development.

Critical independent regions in the VWF propeptide and mature VWF that enable normal VWF storage

Clinical Significance of Inhibitors in Acquired von Willebrand Syndrome

New variant of von Willebrand disease with defective binding to factor VIII

The heterogeneity of type IIA von Willebrand's disease: studies with protease inhibitors

DDAVP enhances platelet adherence and platelet aggregate growth on human artery subendothelium

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only